Radiotherapy boost in patients with hypoxic lesions identified by <sup>18</sup>F-FMISO PET/CT in non-small-cell lung carcinoma: can we expect a better survival outcome without toxicity? [RTEP5 long-term follow-up].

导出原文传递

翻译打印收藏纠错

作者： Pierre,Vera ^[1] ; Sorina-Dana,Mihailescu ^[2] ; Justine,Lequesne ^[2] ; Romain,Modzelewski ^[3] ; Pierre,Bohn ^[3] ; Sébastien,Hapdey ^[3] ; Louis-Ferdinand,Pépin ^[2] ; Bernard,Dubray ^[4] ; Philippe,Chaumet-Riffaud ^[5] ; Pierre,Decazes ^[3] ; Sébastien,Thureau ^[3] ; all investigators of RTEP5 study (list in annexe) ^[4]

作者单位： Department of Nuclear Medicine, Henri Becquerel Cancer Center and Rouen University Hospital, & QuantIF - LITIS [EA (Equipe d'Accueil) 4108 - FR CNRS 3638], Faculty of Medicine, University of Rouen, Rouen, France. pierre.vera@chb.unicancer.fr. ^[1] Department of Statistics and Clinical Research Unit, Henri Becquerel Cancer Center, Rouen, France. ^[2] Department of Nuclear Medicine, Henri Becquerel Cancer Center and Rouen University Hospital, & QuantIF - LITIS [EA (Equipe d'Accueil) 4108 - FR CNRS 3638], Faculty of Medicine, University of Rouen, Rouen, France. ^[3] Department of Radiation Oncology, Henri Becquerel Cancer Center and Rouen University Hospital, & QuantIF - LITIS [EA (Equipe d'Accueil) 4108], Rouen, France. ^[4] Department of Nuclear Medicine, Bicetre Hospital AP-HP and University Paris Sud, Orsay, France. ^[5]

关键词 18F-Fluoromisonidazole Fluorodeoxy-D-glucose Hypoxia Lung cancer Positron emission tomography Radiotherapy dose